Federal appeals court rules that abortion drugs cannot be sent by mail

A federal appeals court ruled that the abortion drug mifepristone cannot be mailed to patients, impacting telehealth access. This decision follows the Supreme Court's 2022 overturning of Roe v. Wade, which led to abortion restrictions in many states.